Informed Consent in IBD Trials: Where We Are and Where We Need to Go-Reference-Cited by-同舟云学术

Informed Consent in IBD Trials: Where We Are and Where We Need to Go

Published:2019-04-16 Issue:7 Volume:25 Page:1115-1119
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Kurin Michael¹^ORCID,Katz Jeffry²,Kodish Eric³,Lashner Bret⁴

Affiliation:

1. Division of Gastroenterology and Liver Diseases, University Hospitals Cleveland Medical Center, Cleveland, Ohio

2. Division of Gastroenterology and Liver Diseases, University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine, Cleveland, Ohio

3. Pediatrics Institute and Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio

4. Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, Ohio

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

http://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izz067/28451126/izz067.pdf

Reference30 articles.

1. Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population;Ha;Clin Gastroenterol Hepatol.,2012

2. Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives;Ravikoff;Inflamm Bowel Dis.,2012

3. Public attitudes toward participation in cancer clinical trials;Comis;J Clin Oncol.,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Informed consent in inflammatory bowel disease: a necessity in real-world clinical practice;Annals of Gastroenterology;2021

2. The management of inflammatory bowel diseases in the era of COVID-19 pandemic: When “non-urgent” does not mean “deferrable”;Digestive and Liver Disease;2020-11

3. Clinical Trials [and Tribulations]: The Immediate Effects of COVID-19 on IBD Clinical Research Activity in the UK;Journal of Crohn's and Colitis;2020-06-29

4. Understanding voluntariness of consent in first-in-human cell therapy trials;Regenerative Medicine;2020-05

5. Listening to the Patient: Improving the Design and Conduct of Clinical Trials in Inflammatory Bowel Diseases;Crohn's & Colitis 360;2020-01-01